These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 8801700

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
    Allard P, Gram L, Timdahl K, Behnke K, Hanson M, Søgaard J.
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of the prescription of antidepressant drugs in elderly nursing home patients: a clinical and laboratory follow-up investigation.
    Chermá MD, Löfgren UB, Almkvist G, Hallert C, Bengtsson F.
    J Clin Psychopharmacol; 2008 Aug; 28(4):424-31. PubMed ID: 18626270
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report.
    Miehle K, Paschke R, Koch CA.
    Pharmacopsychiatry; 2005 Jul; 38(4):181-2. PubMed ID: 16025423
    [Abstract] [Full Text] [Related]

  • 12. De novo onset of Parkinson's disease after antidepressant treatment with citalopram.
    Stadtland C, Erfurth A, Arolt V.
    Pharmacopsychiatry; 2000 Sep; 33(5):194-5. PubMed ID: 11071022
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S, Bodlund O, Agren H.
    J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quetiapine in combination with citalopram in patients with unipolar psychotic depression.
    Konstantinidis A, Hrubos W, Nirnberger G, Windhager E, Lehofer M, Aschauer H, Kasper S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):242-7. PubMed ID: 16962224
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
    Colonna L, Andersen HF, Reines EH.
    Curr Med Res Opin; 2005 Oct 30; 21(10):1659-68. PubMed ID: 16238906
    [Abstract] [Full Text] [Related]

  • 17. Citalopram: interaction studies with levomepromazine, imipramine, and lithium.
    Gram LF, Hansen MG, Sindrup SH, Brøsen K, Poulsen JH, Aaes-Jørgensen T, Overø KF.
    Ther Drug Monit; 1993 Feb 30; 15(1):18-24. PubMed ID: 8451775
    [Abstract] [Full Text] [Related]

  • 18. Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment.
    Barim AO, Aydin S, Colak R, Dag E, Deniz O, Sahin I.
    Clin Biochem; 2009 Jul 30; 42(10-11):1076-81. PubMed ID: 19272368
    [Abstract] [Full Text] [Related]

  • 19. Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation.
    Bondolfi G, Chautems C, Rochat B, Bertschy G, Baumann P.
    Psychopharmacology (Berl); 1996 Dec 30; 128(4):421-5. PubMed ID: 8986013
    [Abstract] [Full Text] [Related]

  • 20. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I, Baruch Y, Barak Y.
    Int Clin Psychopharmacol; 2008 Jan 30; 23(1):49-53. PubMed ID: 18090508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.